Barney is dedicated to improving access to psychedelic medicines. His work with Albert Labs centres around Real-World Evidence in pursuit of licensed psilocybin therapy. He is also the co-founder of the Psychedelic Medicine Association, representing over a thousand clinicians and hundreds of organisations with the mission of bridging the educational gap between advancements in clinical research and healthcare professionals.